TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01700426 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03427879 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT03427879 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03427879 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03427879 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT03045289 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04387682 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT04387682 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT01393184 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03618472 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT01491230 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03353454 — Predictive Biomarker (PRD): ATP8B1 mRNA
Genes: ATP8B1; ATPIC; FIC1; PFIC
Study NCT03277209 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT03624803 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT02083237 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02290275 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01850095 — Predictive Biomarker (PRD): TLR2
Genes: TIL4; CD282
Study NCT03525730 — Predictive Biomarker (PRD): BANF1 mRNA
Genes: BANF1; BAF; BCRG1
Study NCT00459485 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00700414 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT00773695 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00953108 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT04854252 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01879176 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02918409 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00621036 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02546349 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02546349 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02546349 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT04394871 — Predictive Biomarker (PRD): SETX mRNA
Genes: SETX; ALS4; KIAA0625; SCAR1
Study NCT02635581 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00747214 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00826579 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT04070339 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00355472 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study NCT00062166 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT05928923 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00059787 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01805726 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04322149 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT03762499 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00673933 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT00012467 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01631513 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT05862194 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04679272 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02027935 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02027935 — Predictive Biomarker (PRD): CTLA4
Genes: CD152; CD; GSE; CTLA-4
Study NCT01710436 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04097171 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02899949 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00976794 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT01933594 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT01319786 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00262119 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study NCT01157897 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT00429520 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04542850 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01782508 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT03916523 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03324321 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04078438 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04078438 — Safety Biomarker (SAF): BDNF
Study NCT04026685 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01524913 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01347866 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01347866 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01508754 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02217150 — Predictive Biomarker (PRD); Safety Biomarker (SAF): STAR mRNA
Genes: STAR; STARD1
Study NCT00668200 — Surrogate Endpoint (SUR): Serum calcium
Study NCT01401257 — Pharmacodynamic Biomarker (PDY): Peripheral myelin protein 22
Genes: PMP22; GAS3
Study NCT03981549 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00196131 — Predictive Biomarker (PRD): PGP mRNA
Genes: PGP
Study NCT01764295 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00290394 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT00290394 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03326674 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03326674 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02218112 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01036490 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00173537 — Predictive Biomarker (PRD): BMPR2 mRNA
Genes: BMPR2; PPH1
Study NCT02467582 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT01741779 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03117036 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT01772381 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study NCT01235702 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01565265 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00181220 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT05149339 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT05149339 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05149339 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03663387 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT01941940 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02993692 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04455178 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04094376 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT01593696 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03968887 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00288769 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03146182 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02776514 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00072475 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04505709 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00031291 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03403166 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00750308 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00750308 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04944719 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study NCT01943617 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT01943617 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00206492 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00134173 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT00720135 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05100173 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT03043859 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04660435 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04660435 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04660435 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01449201 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01449201 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04644822 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02017730 — Predictive Biomarker (PRD): LPAR1 mRNA
Genes: LPAR1; EDG2; LPA1
Study NCT00312676 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT01369017 — Safety Biomarker (SAF): Interleukin 1
Study NCT02516904 — Predictive Biomarker (PRD): CD101 mRNA
Genes: CD101; EWI101; IGSF2; V7
Study NCT00054041 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02689245 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04462120 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04462120 — Safety Biomarker (SAF): Interleukin 12
Study NCT00040248 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT00040248 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04209881 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00001735 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study NCT02731521 — Pharmacodynamic Biomarker (PDY): 2-hydroxyglutarate
Study NCT02815761 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04425317 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04425317 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT04425317 — Predictive Biomarker (PRD): BSG mRNA
Genes: BSG; UNQ6505/PRO21383
Study NCT04425317 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03415178 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01141686 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01141686 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01141686 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01141686 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study NCT01141686 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT01141686 — Predictive Biomarker (PRD): Ribonucleoside-diphosphate reductase large subunit
Genes: RRM1; RR1
Study NCT01141686 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT02732119 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02732119 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02648776 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT01328587 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT03322384 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT01475006 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02169349 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02169349 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02169349 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00747617 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT03208556 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03208556 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT01589861 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01589861 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01589861 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT01589861 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT00945477 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00945477 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03026972 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02707861 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00988780 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT00560430 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03144011 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study NCT00400894 — Predictive Biomarker (PRD): ANXA3 mRNA
Genes: ANXA3; ANX3
Study NCT01338987 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01853358 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01853358 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01114659 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT00151619 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00968786 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02777567 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02777567 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01970865 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01970865 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT04766541 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT02144558 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT01458106 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT02441244 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03095118 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT01103648 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01103648 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01103648 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03347760 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00945737 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02339506 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT00609245 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT00434629 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01799889 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study NCT01799889 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT02157844 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02157844 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT02157844 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00171535 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05964712 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT03174106 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03196414 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT03196414 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02317705 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT01271270 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01271270 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03096847 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03096847 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03096847 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04422925 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT02159170 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT03585465 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03582280 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02636426 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT02636426 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT01565616 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02487381 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT02119117 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT02908282 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT00009009 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04226573 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04226573 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04241367 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03545789 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00498901 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00504920 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00312312 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT04313049 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04313049 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study NCT04515082 — Predictive Biomarker (PRD): SDC2 mRNA
Genes: SDC2; HSPG1
Study NCT04515082 — Predictive Biomarker (PRD): SFRP2 mRNA
Genes: SFRP2; FRP2; SARP1; FKSG12; UNQ361/PRO697
Study NCT01839513 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03343613 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT00033813 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02497118 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study NCT02497118 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02497118 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00474942 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04820907 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01739335 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT03023059 — Predictive Biomarker (PRD): GPR143 mRNA
Genes: GPR143; OA1
Study NCT03023059 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00933517 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03118570 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03045471 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01726959 — Predictive Biomarker (PRD): DHFR mRNA
Genes: DHFR
Study NCT01726959 — Safety Biomarker (SAF): DHFR
Genes: DHFR1
Study NCT02053675 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT05290649 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT00004038 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03853486 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02002663 — Predictive Biomarker (PRD): ADRB2 mRNA
Genes: ADRB2; ADRB2R; B2AR
Study NCT02002663 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT02002663 — Predictive Biomarker (PRD): UGT2B7 mRNA
Genes: UGT2B7; UGTB2B9
Study NCT02002663 — Safety Biomarker (SAF): OPRM1
Genes: MOR1; MOP
Study NCT02957552 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01688713 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01688713 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01060462 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00270049 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01286389 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1